ATF3: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 02:55, 17 March 2025
ATF3 or Activating Transcription Factor 3 is a protein that in humans is encoded by the ATF3 gene. It is a member of the Activating Transcription Factor/cAMP Responsive Element Binding Protein (ATF/CREB) family of transcription factors.
Function[edit]
ATF3 is a stress-inducible gene and encodes a member of the ATF/CREB family of transcription factors. The encoded protein binds to a consensus sequence of the DNA molecule and regulates the transcription of genes involved in a wide variety of biological responses, including cell proliferation, apoptosis, and immune response.
Clinical Significance[edit]
ATF3 has been implicated in a variety of diseases and conditions. It has been found to be overexpressed in several types of cancer, including breast cancer, prostate cancer, and lung cancer. In addition, it has been associated with neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, as well as cardiovascular diseases and diabetes.
Research[edit]
Research into ATF3 has focused on its role in stress responses and its potential as a therapeutic target in various diseases. Studies have shown that ATF3 can act as a tumor suppressor in certain contexts, but can also promote cancer progression in others. This dual role makes it a complex and intriguing target for therapeutic intervention.
See Also[edit]
References[edit]
<references />
